Avedro

Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking.

Launch date

2007

Employees

Market cap

Enterprise valuation

Waltham Massachusetts (HQ)

Date	Investors	Amount	Round
-	Aperture Ventures Partners Aperture Venture Partners Hercules Capital Western Technology Investment	N/A	-
Jan 2008	DeNovo Ventures Prism Venture Management Echelon Ventures	$8.0m	Series A
Apr 2009	Flagship Pioneering	$10.0m	Series B
Jan 2011	N/A	$6.3m	Early VC
May 2011	N/A	$13.0m	Early VC
Jul 2011	SCP Vitalife Partners	$25.0m	Series C
Feb 2012	N/A	$500k	Early VC
Mar 2013	Abingworth DeNovo Ventures Prism Venture Management Third Point Ventures Flagship Pioneering Echelon Ventures SCP Vitalife Partners	$43.0m	Series D
Apr 2015	N/A	$13.7m	Debt
Nov 2015	InterWest Partners OrbiMed	$32.0m	Series E
Apr 2017	HealthQuest Capital	$42.0m	Early VC
May 2018	InterWest Partners OrbiMed HealthQuest Capital Lilly Asia Ventures	$25.0m	Series F
Feb 2019	N/A	N/A	IPO
Total Funding		$205m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Avedro